Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.65 USD | -2.37% | -6.30% | -16.29% |
04-22 | Citigroup Starts Coverage on Evolent Health With Buy Rating, $40 Price Target | MT |
03-28 | Canaccord Genuity Trims Price Target on Evolent Health to $44 From $45, Maintains Buy Rating | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Bearish | Neutral | Neutral |
Resistance | 30.13 | 34.72 | 34.41 |
Spread/Res. | -8.23% | -20.36% | -19.65% |
Spread/Supp. | +1.28% | +17.01% | +15.30% |
Support | 27.30 | 23.63 | 23.98 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- EVH Stock
- Charts Evolent Health, Inc.